Stockreport

INmune Bio Reports Significant EEG Improvement in Alzheimer's Patients Treated with XPro™ [Yahoo! Finance]

INmune Bio Inc. - Common stock  (INMB) 
PDF Boca Raton, Florida, March 05, 2024 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage immunology company targeting microglial activa [Read more]